Related MeSH Hierarchy (6)
Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Digestive System Neoplasms » Gastrointestinal Neoplasms » Intestinal Neoplasms » Colorectal Neoplasms
Diseases [C] » Digestive System Diseases [C06] » Digestive System Neoplasms » Gastrointestinal Neoplasms » Intestinal Neoplasms » Colorectal Neoplasms
Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Gastrointestinal Neoplasms » Intestinal Neoplasms » Colorectal Neoplasms
Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Intestinal Diseases » Colonic Diseases » Colorectal Neoplasms
Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Intestinal Diseases » Intestinal Neoplasms » Colorectal Neoplasms
Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Intestinal Diseases » Rectal Diseases » Colorectal Neoplasms
Description
Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. MeSH
Hierarchy View
Subtype Terms (4)
Adenomatous Polyposis Coli
37 drugs (17 approved, 20 experimental)
Colonic Neoplasms
440 drugs (197 approved, 243 experimental)
Colorectal Neoplasms, Hereditary Nonpolyposis
23 drugs (17 approved, 6 experimental)
Rectal Neoplasms
236 drugs (114 approved, 122 experimental)
Approved Indicated Drugs (17)
Phase 4 Indicated Drugs (58)
Phase 2 Indicated Drugs (371)
autologous tumor infiltrating lymphocytes
bis-choline tetrathiomolybdate
Efbemalenograstim alpha (Ryzneuta)
fam-trastuzumab deruxtecan-nxki (Enhertu)
gastrin 17 vaccine (Gastrimmune)
gvax pancreatic cancer vaccine
hexyl 5-aminolevulinate (Cysview)
human fecal microbiota (Reybota)
hydroxychloroquine (plaquenil)
Inactivated Mycobacterium obuense
modified vaccinia ankara-5t4 vaccine
radiolabeled albumin technetium Tc-99m albumin colloid kit (Microlite)
Phase 1 Indicated Drugs (353)
23-valent pneumococcal polysaccharide vaccine (pneumovax-23)
autologous dendritic cells loaded with autologous tumor lysate
autologous, engineered t cells targeting tp53 r175h
autologous natural killer cells
bivalent oral polio vaccine (bopv), type 1 and type 3 (BOPV)
boronophenylalanine-fructose complex
cngrc peptide-tnf alpha conjugate
dendritic cell activated cytokine-induced killer cell
hepatitis a vaccine, inactivated (vaqta)
hepatitis b vaccine (recombinant) (Recombivax)
iodine i 131 monoclonal antibody cc49-deltach2
mfe23 scfv-expressing autologous anti-cea mfez t lymphocytes
modified vaccinia virus ankara vaccine expressing p53
nkg2dl-targetting chimeric antigen receptor-grafted gamma delta t cell
pneumococcal 13-valent conjugate vaccine (prevnar 13)
Other Experimental Indicated Drugs (68)
Organization Involved with Phase 4 Indications (62)
Institut de Recherche Clinique sur les Cancers et le Sang
Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
Klinikum Aschaffenburg-Alzenau
Sinphar Pharmaceutical Co., Ltd
Taichung Veterans General Hospital
The Institute of Molecular and Translational Medicine, Czech Republic
Organization Involved with Phase 3 Indications (290)
Anhui College of Traditional Chinese Medicine
Aragon Institute of Health Sciences
Arbeitsgemeinschaft fur Internistische Onkologie (AIO)
Arbeitsgruppe Lebermetastasen und Tumoren
Asian Institute of Gastroenterology
Australasian Gastro-Intestinal Trials Group
Cancer and Leukemia Group B (CALGB)
Cancer Prevention Pharmaceuticals, Inc.
Catholic University of Sacred Heart, Rome
Catholic University of the Sacred Heart
Centre Hospital Universitaire Hop Huriez
China Academy of Chinese Medical Sciences
Chinese Academy of Medical Sciences
D'Annunzio University of Chieti–Pescara
Dutch Health Care Insurance Board
Eastern Cooperative Oncology Group
Egyptian Foundation for Cancer Research
Epidemiological and Clinical Research Information Network
European Organisation for Research and Treatment of Cancer
Federation Francophone de Cancerologie Digestive
First People's Hospital of Foshan
Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente
Gruppo Oncologico Chirurgico Cooperativo Italiano
Gruppo Oncologico del Nord-Ovest
Gruppo Oncologico Italiano di Ricerca Clinica
Guangdong Provincial Hospital of Traditional Chinese Medicine
Hellenic Oncology Research Group
Hôpital Européen Georges-Pompidou
Hospital Universitario Ramon y Cajal
Huazhong University of Science and Technology
Institut de Cancerologie de l'Ouest Paul Papin
Institut Hospitalier Franco-Britannique
Istituto Nazionale per lo Studio e la Cura dei Tumori
Japan Multinational Trial Organization
Katholieke Universiteit Leuven
Meizhou City Hospital Of Guangdong Provience
Moorgreen Hospital, Southampton
Multicenter Clinical Study Group of Osaka
Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group
National Cancer Institute, France
National Cancer Institute (NCI)
National Cancer Institute of Thailand
National Health and Medical Research Council, Australia
National Heart, Lung, and Blood Institute (NHLBI)
National Hospital Organization Kyoto Medical Center
National Institutes of Health (NIH)
National University of Singapore
North Central Cancer Treatment Group
Northern California Cancer Center
Onkologische Schwerpunktpraxis Eppendorf
People's Liberation Army of China
Pierre and Marie Curie University
Presidio Ospedaliero di Livorno
Prologue Research International
Qidong Gaitianli Medicines Co., Ltd
Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust
Royal Marsden Hospital NHS Trust
Second Military Medical University
Shandong Provincal Cancer Hospital
Shanghai Biomabs Pharmaceuticals Co Ltd
Shanghai Zhangjiang Biotechnology Limited Company
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Simcere Pharmaceutical Co., Ltd
Southern Italy Cooperative Oncology Group
Spanish Cooperative Group for Gastrointestinal Tumour Therapy
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Swiss Group for Clinical Cancer Research
Taizhou Mabtech Pharmaceutical Co., Ltd.
The First People's Hospital of Changzhou
The Nordic Colorectal Cancer Biomodulation Group
Tokyo Medical and Dental University
Translational Research Informatics Center, Kobe, Hyogo, Japan
Universidad Autonoma de Barcelona
Universitaetsklinikum Schleswig-Holstein
University of California, Irvine
University of California, Los Angeles
University of California, San Francisco
University of Nice Sophia Antipolis
University of North Carolina at Chapel Hill
University of Southern California
University of Southern Denmark
University of Texas at Houston
ZonMw: The Netherlands Organisation for Health Research and Development
Organization Involved with Phase 2 Indications (500)
Academic and Community Cancer Research United
Arbeitsgemeinschaft medikamentoese Tumortherapie
Assistance Publique - Hôpitaux de Paris
Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socials
Association pour la Recherche sur le Temps Biologique et la Chronothérapie
Austrian Breast and Colorectal Cancer Group
Austrian Society Of Surgical Oncology
Azienda Ospedaliera Antonio Cardarelli
Azienda Sanitaria Rummo, Benevento, Division of Medical Oncology
Badalona Hospital Germans Trias i Pujol
Beijing Genova Biotech Company, Ltd.
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.
Biocompatibles International plc
Biotech Pharmaceutical Co., Ltd.
British Columbia Cancer Agency
Cancer League of Colorado, Inc
Cancer Treatment Centers of America
Cantonal Hospital of St. Gallen
Case Western Reserve University
Central European Cooperative Oncology Group
Central European Society for Anticancer Drug Research (CESAR)
Centre Georges Francois Leclerc
Centre Hospitalier de Belfort-Montbelliard
Centre Hospitalier du Mittan-MONTBELIARD
Centre Hospitalier La Source, Orleans
Chao Family Comprehensive Cancer Center
Chinese University of Hong Kong
Chongqing Precision Biotech Co., Ltd
City of Hope National Medical Center
Clinica Universidad de Navarra
CSSS Champlain - Charles-Lemoyne Hospital
Desert Regional Comprehensive Cancer Center
Developmental Therapeutics Consortium
Doris Duke Charitable Foundation
Federal State Institution of Health of the Yaroslav Region Regional Clinical Oncology Hospital
Fondazione del Piemonte per l'Oncologia
Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milano
Fundacion CRIS de Investigación para Vencer el Cáncer
Generic Devices Consulting, Inc.
Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH
Grande Ospedale Metropolitano Niguarda - Milano
Groupe hospitalier St Joseph-PARIS
Grupo de Investigacao do Cancro Digestivo
Grupo Espanol Multidisciplinario del Cancer Digestivo
Grupo Oncologico Cooperativo del Sur
Hellenic Cooperative Oncology Group
Herbert Irving Comprehensive Cancer Center
Hiroshima Prefectural Hospital
Hoosier Cancer Research Network
Hopital Rene Huguenin_Intitut Curie_Paris
Hospital Clinico de Santiago, Spain
Hospital de Fuenlabrada de Madrid
Hospital de Sant Pau i Santa Tecla de Tarragona
Hospital General Universitario de Castellón
Hospital general Universitario de Ciudad Real
Hospital General Universitario Gregorio Marañon
Hospital of Southern Norway Trust
Hospital Universitario Arnau de Vilanova de Lleida
Hospital Universitario de Fuenlabrada
Hospital Universitario Puerta del Mar
Hospital Universitari Son Dureta
Icahn School of Medicine at Mount Sinai
Innovent Biologics (Suzhou) Co. Ltd.
Instituto de Investigación Sanitaria Aragón
Instituto do Cancer do Estado de São Paulo
International Drug Development Institute
Istituti Fisioterapici Ospitalieri
Istituti Ospitalieri di Cremona
Istituto Clinico Humanitas - Rozzano (MI), Italy
Istituto Nazionale dei Tumori di Napoli - IRCCS - Fondazione G. Pascale
Japan Clinical Cancer Research Organization
Jiangsu Cancer Institute & Hospital
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Laboratorio Elea S.A.C.I.F. y A.
Leaders In Oncology Care, Harley St, London
Lotte & John Hecht Memorial Foundation
Memorial Sloan-Kettering Cancer Center
National Cancer Center Hospital East
National Cancer Institute, Egypt
National Cancer Institute, Italy
National Cheng Kung University
National Comprehensive Cancer Network
Nationales Centrum fur Tumorerkrankungen
National Hospital Organisation Shikoku Cancer Centre
National Hospital Organization Osaka National Hospital
Northeast Ohio Medical University
Norwegian University of Science and Technology
Olivia Newton-John Cancer Research Institute
Ontario Cancer Research Network
Oregon Health and Science University
Ottawa Regional Cancer Foundation
People's Hospital of Zhongshan
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Polo Oncologico Area Vasta Nord Ovest
Qingdao Zhixin Health Technology Co., Ltd.
Quebec Clinical Research Organization in Cancer
Radiation Oncology Center of Olathe
Radiation Therapy Oncology Group
San Carlos University Hospital, Madrid
Second People's Hospital of Yibin
Shanghai Junshi Bioscience Co.,Ltd.
Shenzhen Hank Bioengineering Institute
Shenzhen Hornetcorn Bio-technology Company, LTD
Southwestern Regional Medical Center
STABIL - Statistische und Biometrische Lösungen
State University of New York, Buffalo
St. Marianna University School of Medicine
Sunshine Lake Pharma Co., Ltd.
Technical University of Dresden
The Beatson West of Scotland Cancer Centre
The Beijing Pregene Science and Technology Company, Ltd.
The Christie NHS Foundation Trust
The First People's Hospital of Jingzhou
The Jewish General Hospital, Montreal QC, Canada
The Scientific and Technological Research Council of Turkey
The University of Texas, Dallas
Translational Drug Development
Translational Oncology Research International
Unidad Integral de Investigación en Oncología S.L.
Universidad Autonoma de Madrid
Universidad Complutense de Madrid
Université catholique de Louvain
University of Alabama, Birmingham
University of British Columbia
University of California, Davis
University of California, San Diego
University of Campania Luigi Vanvitelli
University of Colorado, Denver
University of Illinois at Chicago
University of Las Palmas de Gran Canaria
University of Medicine and Dentistry of New Jersey
University of Medicine and Pharmacy Cluj-Napoca, Romania
University of Texas, San Antonio
Val d'Aurelle Cancer Institute
Vita-Salute University of Milano. Italy
Washington University in St. Louis
Western General Hospital, Australia
Western Hospital, Footscray, Victoria. Australia
Organization Involved with Phase 1 Indications (84)
CPR Pharma Services Pty Ltd, Australia
Dynavax Technologies Corporation
Gottfried Wilhelm Leibniz Universität Hannover
GSO Global Clinical Research BV
Holy Stone Healthcare Co., Ltd
HuaDao (Shanghai) Biomedical Co., Ltd.
Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor
Lipomedix Pharmaceuticals Inc.
Ludwig Institute for Cancer Research
National University of Ireland
Oncology Therapeutic Development
Organization Involved with Other Experimental Indications (41)
Centro de Pesquisas Oncológicas de Florianópolis
Ciusss de L'Est de l'Île de Montréal
Federal University of Santa Catarina
Fundação de Amparo à Pesquisa do Estado de São Paulo
Gottfried und Julia Bangerter-Rhyner Foundation, Switzerland
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
